← The Wire
INVANasdaq
Innoviva, Inc.
Pharmaceutical Preparations · DE · CIK 1080014
Innoviva is a biopharmaceutical company with a royalty portfolio, a critical care and infectious disease platform, and strategic healthcare assets
red 8-K · 90d
$1.68B
Market cap
$23.14
Last close
-1.8%
1D
+2.1%
5D
879K
Volume
Price · last 39 sessions+0.7%
May 4L $21.35 · H $23.64Jun 29
387
Total filings
May 18, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeMay 18, 202610-Q10-QMay 6, 20268-KResults of OperationsMay 6, 20268-KShareholder VoteMay 4, 202610-K/A10-K/AMar 27, 2026DEF 14ADEF 14AMar 24, 20268-KResults of OperationsFeb 25, 202610-K10-KFeb 25, 202610-Q10-QNov 5, 20258-KResults of OperationsNov 5, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder VoteMay 21, 202510-Q10-QMay 7, 20258-KResults of OperationsMay 7, 2025DEFA14ADEFA14AApr 8, 2025DEF 14ADEF 14AApr 8, 202510-K/A10-K/AMar 24, 202510-K10-KFeb 26, 20258-KResults of OperationsFeb 26, 202510-Q10-QNov 6, 20248-KResults of OperationsNov 6, 202410-Q10-QJul 31, 20248-KResults of OperationsJul 31, 20248-KShareholder VoteJun 20, 20248-KReg FD DisclosureMay 13, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 20248-KExecutive ChangeApr 30, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 202410-K/A10-K/AMar 22, 202410-K/A10-K/AMar 5, 202410-K10-KFeb 29, 20248-KResults of OperationsFeb 29, 2024SC 13GSEC SCHEDULE 13GFeb 9, 20248-KReg FD DisclosureNov 6, 202310-Q10-QNov 1, 20238-KResults of OperationsNov 1, 20238-KExecutive Change · Reg FD DisclosureAug 25, 20238-KDelisting NoticeAug 7, 202310-Q10-QAug 2, 20238-KResults of OperationsAug 2, 20238-KExecutive Change · Reg FD DisclosureJul 11, 20238-KReg FD DisclosureMay 24, 20238-KShareholder VoteMay 24, 2023DEFA14ADEFA14AMay 17, 20238-KResults of OperationsMay 9, 202310-Q10-QMay 9, 2023DEFA14ADEFA14AMay 1, 20238-KExecutive Change · Reg FD DisclosureMay 1, 2023DEF 14ADEF 14AApr 28, 202310-K/A10-K/AMar 20, 20238-KResults of OperationsFeb 28, 202310-K10-KFeb 28, 2023SC 13GSC 13GFeb 14, 2023SC 13GSC 13GJan 20, 20238-KExecutive Change · Bylaw AmendmentJan 4, 202310-Q10-QNov 9, 20228-KResults of OperationsNov 9, 20228-K/AAcquisition / DispositionOct 28, 20228-KReg FD DisclosureSep 14, 20228-KCompany UpdateAug 23, 20228-KAcquisition / Disposition · Company UpdateAug 22, 202210-Q10-QJul 27, 20228-KResults of OperationsJul 27, 20228-KMaterial AgreementJul 20, 20228-KMaterial Agreement · Company UpdateJul 13, 20228-KAcquisition / Disposition · Company UpdateJul 11, 20228-KMaterial Agreement · Company UpdateJul 11, 2022425425Jul 11, 20228-KMaterial Agreement · Company UpdateMay 24, 202210-Q10-QMay 5, 20228-K/AExecutive ChangeMay 4, 20228-KExecutive ChangeMay 2, 20228-KShareholder VoteApr 29, 20228-KResults of OperationsApr 28, 20228-KReg FD DisclosureApr 7, 20228-KMaterial AgreementApr 1, 2022DEF 14ADEF 14AMar 25, 2022
Similar companies
Comparable business profile · signals at a glance